-
NACI update: A new tool to protect infants from RSV
The National Advisory Committee on Immunization recommends adding clesrovimab to the arsenal of preventive measures against respiratory syncytial virus in infants and young children. This monoclonal antibody was approved by Health Canada in February 2026.

